Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhihao He
Institutions:
University of Auckland,
Capital Medical University,
Beijing Friendship Hospital
Observed institutions:
University of Auckland,
Capital Medical University,
Beijing Friendship Hospital
ORCID:
0000-0002-2176-3424
Observed ORCID:
0000-0002-2176-3424
OpenAlex ID:
A5048469395
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
2022
·
Yuting Lu
, Xiangliang Yuan
, et al.
·
Journal of Hematology & Oncology
·
556
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
2024
·
Haiqing Zhao
, Wei Zhang
, et al.
·
Cancer Medicine
·
22
PDF
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study
2026
·
Zhihao He
, Yifei Chen
, et al.
·
Journal of Clinical Medicine
Safety and efficacy of TROP2-directed ADCs in HER2-negative breast cancer: A systematic review and network meta-analysis
2026
·
Xiaoning Wu
, Qin Li
, et al.
·
Therapeutic Advances in Medical Oncology
Integrative multi-omics and mendelian randomization reveal the critical role of pyroptosis in prognosis and therapy of lung squamous cell carcinomas
2026
·
Taihao Wang
, Wei Zhang
, et al.
·
Frontiers in Cell and Developmental Biology
PDF
A Novel Modulation for Reducing Coil VA and Loss in Misaligned Three-Phase IPT Systems
2026
·
Zhihao He
, Duleepa J. Thrimawithana
, et al.
·
IEEE Transactions on Industrial Electronics
Integrated metabolic and immune profiling analysis reveals distinct prognostic signatures for neoadjuvant immunotherapy in locally advanced esophageal cancer
2023
·
Yuting Lu
, Chunquan Liu
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
7
Citation count:
578
H-index:
2
I10-index:
2
Year
Topic
Type